NEW YORK (GenomeWeb News) - Sequenom said today that MetaMorphix will expand its use of Sequenom’s MassARRAY and iPlex technologies for its genotyping and selection services.
The agreement extends an earlier partnership that the companies signed in 2005.
The new agreement will allow MMI to handle increased sample orders coming from its DNA-based livestock and companion animal diagnostic products, Sequenom said.
Last year MMI released seed-stock and feedlot management products through a partnership with the agricultural company Cargill. MMI also offers the Canine Heritage Breed test, which customers use to determine the breed composition of mixed breed dogs.
Sequenom’s CEO, Harry Stylii, said the MassARRAY is a “a synergistic fit for MMI's genotyping endeavors as it is highly suitable for cost effective testing of a large number of DNA samples."
Financial terms of the agreement were not released.